Seven Eight Capital, LP Abiomed Inc Transaction History

Seven Eight Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $2.04 Million - $3.24 Million	-11,600 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$250.96 - $284.94 $2.91 Million - $3.31 Million	11,600 New	11,600 $3.02 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $337,296 - $533,100	-1,200 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$278.07 - $446.21 $333,684 - $535,452	1,200 New	1,200 $491,000
Q3 2017 Oct 16, 2017	SELL	$145.39 - $168.6 $101,772 - $118,020	-700 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	700	700 $100,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.